Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
Human parainfluenza viruses (HPIVs) are a major health concern in infants and young children under 5 years of age, causing serious respiratory tract disease. The purpose of this study is to test the safety of and immune response to a new HPIV vaccine in healthy infants, children, and adults.
Epistemonikos ID: 58b44fb54b452d516a696586f31747859de41958
First added on: Mar 23, 2020